20
Dipharma Francis Srl, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CYCLOBENZAPRINE HCL, with a corresponding US DMF Number 5864.
Remarkably, this DMF maintains an Active status since its submission on June 06, 1985, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 23, 2015, and payment made on June 17, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II